Logo image of P911.DE

DR ING HC F PORSCHE AG (P911.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:P911 - DE000PAG9113

44.28 EUR
-0.06 (-0.14%)
Last: 1/13/2026, 4:11:15 PM
Fundamental Rating

5

Taking everything into account, P911 scores 5 out of 10 in our fundamental rating. P911 was compared to 29 industry peers in the Automobiles industry. While P911 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. P911 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

P911 had positive earnings in the past year.
In the past year P911 had a positive cash flow from operations.
In the past 5 years P911 has always been profitable.
Each year in the past 5 years P911 had a positive operating cash flow.
P911.DE Yearly Net Income VS EBIT VS OCF VS FCFP911.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

P911 has a Return On Assets of 3.88%. This is in the better half of the industry: P911 outperforms 75.86% of its industry peers.
Looking at the Return On Equity, with a value of 9.19%, P911 is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
P911 has a better Return On Invested Capital (6.83%) than 79.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for P911 is significantly above the industry average of 6.42%.
The 3 year average ROIC (13.25%) for P911 is well above the current ROIC(6.83%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROIC 6.83%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
P911.DE Yearly ROA, ROE, ROICP911.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

P911's Profit Margin of 3.69% is fine compared to the rest of the industry. P911 outperforms 65.52% of its industry peers.
P911's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.64%, P911 is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
In the last couple of years the Operating Margin of P911 has declined.
P911's Gross Margin of 18.85% is fine compared to the rest of the industry. P911 outperforms 62.07% of its industry peers.
P911's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
P911.DE Yearly Profit, Operating, Gross MarginsP911.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

P911 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for P911 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, P911 has about the same amount of shares outstanding.
The debt/assets ratio for P911 is higher compared to a year ago.
P911.DE Yearly Shares OutstandingP911.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
P911.DE Yearly Total Debt VS Total AssetsP911.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

The Debt to FCF ratio of P911 is 5.28, which is a neutral value as it means it would take P911, 5.28 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.28, P911 belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that P911 is not too dependend on debt financing.
The Debt to Equity ratio of P911 (0.29) is better than 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Altman-Z N/A
ROIC/WACC1.08
WACC6.3%
P911.DE Yearly LT Debt VS Equity VS FCFP911.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

P911 has a Current Ratio of 1.35. This is a normal value and indicates that P911 is financially healthy and should not expect problems in meeting its short term obligations.
P911 has a Current ratio of 1.35. This is in the better half of the industry: P911 outperforms 79.31% of its industry peers.
P911 has a Quick Ratio of 1.35. This is a bad value and indicates that P911 is not financially healthy enough and could expect problems in meeting its short term obligations.
P911 has a better Quick ratio (0.96) than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.96
P911.DE Yearly Current Assets VS Current LiabilitesP911.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2

3. Growth

3.1 Past

The earnings per share for P911 have decreased strongly by -30.27% in the last year.
P911 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
The Revenue has decreased by -1.10% in the past year.
Measured over the past years, P911 shows a small growth in Revenue. The Revenue has been growing by 7.05% on average per year.
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%

3.2 Future

P911 is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.33% yearly.
Based on estimates for the next years, P911 will show a small growth in Revenue. The Revenue will grow by 2.96% on average per year.
EPS Next Y-83.72%
EPS Next 2Y-22.13%
EPS Next 3Y-9.9%
EPS Next 5Y-0.33%
Revenue Next Year-5.99%
Revenue Next 2Y-2.46%
Revenue Next 3Y-0.75%
Revenue Next 5Y2.96%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
P911.DE Yearly Revenue VS EstimatesP911.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B 50B
P911.DE Yearly EPS VS EstimatesP911.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

P911 is valuated reasonably with a Price/Earnings ratio of 11.24.
65.52% of the companies in the same industry are more expensive than P911, based on the Price/Earnings ratio.
P911 is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 18.53 indicates a rather expensive valuation of P911.
Compared to the rest of the industry, the Price/Forward Earnings ratio of P911 indicates a slightly more expensive valuation: P911 is more expensive than 62.07% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.98. P911 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 11.24
Fwd PE 18.53
P911.DE Price Earnings VS Forward Price EarningsP911.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, P911 is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, P911 is valued a bit cheaper than 72.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.32
EV/EBITDA 1.37
P911.DE Per share dataP911.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of P911 may justify a higher PE ratio.
A cheap valuation may be justified as P911's earnings are expected to decrease with -9.90% in the coming years.
PEG (NY)N/A
PEG (5Y)2.2
EPS Next 2Y-22.13%
EPS Next 3Y-9.9%

4

5. Dividend

5.1 Amount

P911 has a Yearly Dividend Yield of 4.92%, which is a nice return.
Compared to an average industry Dividend Yield of 3.63, P911 pays a bit more dividend than its industry peers.
P911's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 4.92%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
P911.DE Yearly Dividends per shareP911.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

100.96% of the earnings are spent on dividend by P911. This is not a sustainable payout ratio.
DP100.96%
EPS Next 2Y-22.13%
EPS Next 3Y-9.9%
P911.DE Yearly Income VS Free CF VS DividendP911.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
P911.DE Dividend Payout.P911.DE Dividend Payout, showing the Payout Ratio.P911.DE Dividend Payout.PayoutRetained Earnings

DR ING HC F PORSCHE AG

FRA:P911 (1/13/2026, 4:11:15 PM)

44.28

-0.06 (-0.14%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-10 2025-10-10/amc
Earnings (Next)03-11 2026-03-11
Inst Owners11.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.17B
Revenue(TTM)56.35B
Net Income(TTM)2.08B
Analysts53.75
Price Target46.35 (4.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.92%
Yearly Dividend2.31
Dividend Growth(5Y)N/A
DP100.96%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-98.95%
Min EPS beat(2)-263.81%
Max EPS beat(2)65.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.24%
Min Revenue beat(2)-9.69%
Max Revenue beat(2)-0.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.38%
PT rev (3m)4.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.64%
EPS NY rev (1m)2.07%
EPS NY rev (3m)-62.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.07%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 11.24
Fwd PE 18.53
P/S 0.36
P/FCF 9.32
P/OCF 4.16
P/B 0.89
P/tB 1.4
EV/EBITDA 1.37
EPS(TTM)3.94
EY8.9%
EPS(NY)2.39
Fwd EY5.4%
FCF(TTM)4.75
FCFY10.73%
OCF(TTM)10.64
OCFY24.03%
SpS123.71
BVpS49.69
TBVpS31.71
PEG (NY)N/A
PEG (5Y)2.2
Graham Number66.37
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROCE 9.85%
ROIC 6.83%
ROICexc 10.13%
ROICexgc 14.89%
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
FCFM 3.84%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
ROICexc(3y)18.5%
ROICexc(5y)16.21%
ROICexgc(3y)27.68%
ROICexgc(5y)23.14%
ROCE(3y)19.1%
ROCE(5y)16.92%
ROICexgc growth 3Y2.85%
ROICexgc growth 5Y3.55%
ROICexc growth 3Y-0.44%
ROICexc growth 5Y1.03%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Debt/EBITDA 0.73
Cap/Depr 52.89%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 54.98%
Profit Quality 103.99%
Current Ratio 1.35
Quick Ratio 0.96
Altman-Z N/A
F-Score5
WACC6.3%
ROIC/WACC1.08
Cap/Depr(3y)107.61%
Cap/Depr(5y)100.02%
Cap/Sales(3y)9.74%
Cap/Sales(5y)9.61%
Profit Quality(3y)66.21%
Profit Quality(5y)65.11%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
EPS Next Y-83.72%
EPS Next 2Y-22.13%
EPS Next 3Y-9.9%
EPS Next 5Y-0.33%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%
Revenue Next Year-5.99%
Revenue Next 2Y-2.46%
Revenue Next 3Y-0.75%
Revenue Next 5Y2.96%
EBIT growth 1Y-21.15%
EBIT growth 3Y2.63%
EBIT growth 5Y5.02%
EBIT Next Year-6.65%
EBIT Next 3Y11.87%
EBIT Next 5Y16.13%
FCF growth 1Y431.7%
FCF growth 3Y-8.36%
FCF growth 5Y11.7%
OCF growth 1Y-30.9%
OCF growth 3Y-0.33%
OCF growth 5Y7.21%

DR ING HC F PORSCHE AG / P911.DE FAQ

Can you provide the ChartMill fundamental rating for DR ING HC F PORSCHE AG?

ChartMill assigns a fundamental rating of 5 / 10 to P911.DE.


What is the valuation status of DR ING HC F PORSCHE AG (P911.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to DR ING HC F PORSCHE AG (P911.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DR ING HC F PORSCHE AG?

DR ING HC F PORSCHE AG (P911.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for P911 stock?

The Price/Earnings (PE) ratio for DR ING HC F PORSCHE AG (P911.DE) is 11.24 and the Price/Book (PB) ratio is 0.89.


How financially healthy is DR ING HC F PORSCHE AG?

The financial health rating of DR ING HC F PORSCHE AG (P911.DE) is 4 / 10.